Next Article in Journal
Rapid and Sensitive Detection of Cardiac Troponin I for Point-of-Care Tests Based on Red Fluorescent Microspheres
Next Article in Special Issue
Improved Synthesis of N-Methylcadaverine
Previous Article in Journal
Dehalogenases: From Improved Performance to Potential Microbial Dehalogenation Applications
Previous Article in Special Issue
The Effects of Plant-Derived Oleanolic Acid on Selected Parameters of Glucose Homeostasis in a Diet-Induced Pre-Diabetic Rat Model
Article

Ursolic Acid Attenuates Atherosclerosis in ApoE−/− Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway

by 1, 2, 2 and 3,*
1
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR 999078, China
2
Department of Pharmacology, College of basic Medicine, Qingdao University, 308 Ningxia Road, Qingdao 266000, China
3
Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao 266000, China
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(5), 1101; https://doi.org/10.3390/molecules23051101
Received: 28 March 2018 / Revised: 19 April 2018 / Accepted: 28 April 2018 / Published: 7 May 2018
Atherosclerosis, a chronic inflammatory disease, is a major contributor to cardiovascular diseases. Ursolic acid (UA) is a phytonutrient with widely biological effects including anti-oxidative, anti-inflammatory, and so on. At present, the effect of UA on atherosclerosis and the mechanism of action are still obscure. This study focused on investigating the effects of UA on atherosclerosis both in vivo and in vitro. We first selected LOX-1 as our target, which was reckoned as a new promising receptor for treating atherosclerosis. The evaluation in vitro suggested that UA significantly decreased endothelial LOX-1 expression induced by LPS both in mRNA and protein levels. Pre-treatment of UA also inhibited TLR4/MyD88 signaling activated by LPS. Moreover, UA reduced ROS production and suppressed the activation of NF-κB stimulated by LPS. Particularly, the evaluation in vivo further verified the conclusion obtained in vitro. In ApoE−/− mice fed with an atherogenic diet, both UA (100 mg/kg/day) and simvastatin significantly attenuated atherosclerotic plaque formation and shrunk necrotic core areas. The enhanced expression of LOX-1 in atherosclerotic aorta was also dramatically decreased by administration of UA. Taken together, these results suggested that UA, with anti-atherosclerotic activity through inhibition of LOX-1 mediated by ROS/NF-κB signaling pathways, may become a valuable vascular protective candidate for the treatment of atherosclerosis. View Full-Text
Keywords: atherosclerosis; ROS; HUVECs; LOX-1 atherosclerosis; ROS; HUVECs; LOX-1
Show Figures

Graphical abstract

MDPI and ACS Style

Li, Q.; Zhao, W.; Zeng, X.; Hao, Z. Ursolic Acid Attenuates Atherosclerosis in ApoE−/− Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway. Molecules 2018, 23, 1101. https://doi.org/10.3390/molecules23051101

AMA Style

Li Q, Zhao W, Zeng X, Hao Z. Ursolic Acid Attenuates Atherosclerosis in ApoE−/− Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway. Molecules. 2018; 23(5):1101. https://doi.org/10.3390/molecules23051101

Chicago/Turabian Style

Li, Qiu, Wenwen Zhao, Xi Zeng, and Zhihui Hao. 2018. "Ursolic Acid Attenuates Atherosclerosis in ApoE−/− Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway" Molecules 23, no. 5: 1101. https://doi.org/10.3390/molecules23051101

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop